Nat Med 2006, 12:852–855 PubMedCrossRef 13 Asano H, Toyooka S, T

Nat Med 2006, 12:852–855.PubMedCrossRef 13. Asano H, Toyooka S, Tokumo M, Ichimura K, Aoe K, Ito S, Tsukuda K, Ouchida M, Aoe M, Katayama H, Hiraki A, Sugi K, Kiura K, Date H, Shimizu N: Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay. Clin Cancer Res 2006, 12:43–48.PubMedCrossRef 14. Hoshi K, Takakura H, Mitani Y, Tatsumi K, Momiyama N, Ichikawa XAV-939 supplier Y, Togo S, Miyagi T, Kawai Y, Kogo Y, Kikuchi T, Kato C, Arakawa T, Uno S, Cizdziel PE, Lezhava A, Ogawa

N, Hayashizaki Y, Shimada H: Rapid detection of epidermal growth factor receptor mutations in lung cancer by the SMart-Amplification Process. Clin Cancer Res 2007, 13:4974–4983.PubMedCrossRef 15. Pao W, Ladanyi M: Epidermal growth factor receptor mutation testing in lung cancer: searching for the ideal method. Clin Cancer Res 2007, 13:4954–4955.PubMedCrossRef

16. Kimura H, Kasahara K, Kawaishi M, Kunitoh H, Tamura T, Holloway B, Nishio K: Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with Volasertib chemical structure non-small-cell lung cancer. Clin Cancer Res 2006, 12:3915–3921.PubMedCrossRef 17. Nagai Y, Miyazawa H, Huqun , Tanaka T, Udagawa K, Kato M, Fukuyama S, Yokote A, Kobayashi K, Kanazawa M, Hagiwara K: Genetic heterogeneity of the epidermal growth factor receptor in non-small GSK621 supplier HDAC inhibitor cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp. Cancer Res 2005, 65:7276–7282.PubMedCrossRef 18. John T, Liu G, Tsao MS: Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy

number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors. Oncogene 2009,28(Suppl 1):S14-S23.PubMedCrossRef 19. Stroun M, Maurice P, Vasioukhin V, Lyautey J, Lederrey C, Lefort F, Rossier A, Chen XQ, Anker P: The origin and mechanism of circulating DNA. Ann N Y Acad Sci 2000, 906:161–168.PubMedCrossRef 20. Stroun M, Lyautey J, Lederrey C, Olson-Sand A, Anker P: About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta 2001, 313:139–142.PubMedCrossRef 21. Aung KL, Board RE, Ellison G, Donald E, Ward T, Clack G, Ranson M, Hughes A, Newman W, Dive C: Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours. Hugo J 2010, 4:11–21.PubMedCrossRef 22.

Comments are closed.